Publication: Flecainide With Ranolazine Combination Inhibits Nav 1.5 Activity of Triple-Negative Breast Cancer Cells (MDA-MB-231)
Loading...
Date
KU Authors
Authors
item.page.advisor
Journal Title
Journal ISSN
Volume Title
Type
Publisher
item.page.alternative
Abstract
Description
Keywords
Citation
Mammadova, G., Demirel, M., & Altun, S. (2025, July). Flecainide with ranolazine combination inhibits Nav 1.5 activity of triple-negative breast cancer cells (MDA-MB-231). In FEBS OPEN BIO (Vol. 15, pp. 303-303). 111 RIVER ST, HOBOKEN 07030-5774, NJ USA: WILEY.